Aluminium is known to be toxic to cells from bone, brain and bone marrow but the molecular target(s) affected by A13+ are not known. We show here that A13+ disrupts the oscillatory free Ca2+ responses of hepatocytes exposed to the Ca2+-mobilizing agonist phenylephrine. A13+ initially increases the frequency of the oscillations and later induces broad Ca2+ spikes lasting several minutes. These broad spikes persist after removal of both agonist and Al3+ from the medium. In the absence of agonist, Al3+ has no effect on free Ca2+. The data suggest that some component(s) of the receptorphosphoinositide-Ca2+ signalling pathway might be the site at which Al3+ exerts toxic effects.
INTRODUCTION
Aluminium is the causative agent in the anaemia, osteodystrophy and encephalopathy associated with long-term dialysis using aluminium-rich diffusate [1] [2] [3] . Aluminium has been implicated in the aetiology of Alzheimer's disease, being found, associated with silicon, in the senile plaques characteristic of this disorder [4] [5] [6] ; its environmental availability has been implicated in the epidemiology of Alzheimer's disease [7] . The release of aluminium into the environment under acidic conditions is implicated in the toxic effect of acid rain on fish and plants [8, 9] . Moreover, aluminium has been found to affect a variety of biological systems both in vivo and in vitro [10] [11] [12] [13] . The exact molecular mechanisms involved in the varied toxicology of aluminium are not known but are generally attributed to the ability of A13+ to displace Mg2+ at binding sites where Mg2+ is an essential catalytic cofactor. The much stronger binding of A13+ and the IO' times slower ligand exchange rate are then responsible for the inhibition of activity. Citrate is a strong complexing agent for A13+ which is able to prevent the binding of A13+ by ATP [11] and by the phosphate groups of phospholipid vesicles [14] . However, it has been proposed by one of us [15] concentrations. Control experiments using 50 /tM-sodium citrate had no effect on free Ca2+ responses to phenylephrine. Desferrioxamine (supplied by Ciba Laboratories, Horsham, Sussex, U.K.), was stored at 5 'C. Unfortunately, EGTA binds A13+ avidly [13] , making calibration of aequorin in vitro at known free Ca2+ levels in the presence of known free Al3+ concentrations extremely difficult to achieve. However, A13+ is prevented from binding to calmodulin when excess citrate is present [19] , so aequorin is unlikely to be affected directly by AP3+ in these experiments. All other aspects of the technique were as previously described [16, 17] .
RESULTS Fig. 1 shows that repetitive free Ca2+ transients induced by phenylephrine were modified by superfusion-of medium containing 10,M-Al3+/50 /aM-citrate. The earliest detectable effect was an increase in the frequency of the transients, starting within 5 min after the addition of aluminium citrate. This was a consistent effect (also visible in Fig. 3 ). The decrease in peak free Ca2` (Fig. la) Fig. 2(a) shows that the effects of Al3+ depended upon the presence of an agonist. However, when agonist was added to a cell after a period of 0.5 h in aluminium citrate, no response to phenylephrine was found (Fig. 2b) . In the experimental protocol depicted in Fig. 1 [20] . Control experiments in which sodium citrate alone (50,UM) was added to the medium showed no effects whether or not phenylephrine was present (five cells;
results not shown). Since removal of extracellular Al3+ failed to reverse its effects (Fig. lb) , we attempted to chelate intracellular Al3+ using desferrioxamine, which has a high affinity for Al3+ (log stability constant = 22 [21] ) and which may be cell-permeant [22] . Fig. 3 Of these six cells, that depicted in Fig. 3(b) showed the most pronounced recovery. Early addition of desferrioxamine, at the point where Al3+ had accelerated transient frequency but had not yet induced the large irregular spikes (Fig. 3c) [16, 17] . Fig. 2 clearly shows that in the absence of a Ca2+-mobilizing agonist, free Ca2+ remains at resting levels. When an agonist is present, addition of aluminium citrate leads initially to an increase in the frequency of the repetitive free Ca2+ transients (Figs. 1 and 3) . The maximum frequency observed is approx. 2 min-', corresponding to a period of around 30 s. This is similar to the maximum frequency observed (in the absence of Al3+) in cells exposed to higher concentrations of phenylephrine (10 flM and above [16, 17] ). Thus at this point the effect of Al3+ appears to potentiate rather than block the effects of agonists on free Ca2+ spiking. We have proposed that the intertransient interval represents a period in which a GTP-liganded G-protein is accumulating, under the influence of agonist-occupied receptor, towards a threshold level of GTP-G-protein sufficient to trigger a free Ca2+ transient [23] [24] [25] . In view of evidence that Al3+ can inhibit the hydrolysis of GTP by G-proteins such as transducin [13] , one possibility is that the increased frequency of free Ca2+ transients is caused by a decrease of GTP hydrolysis by Gproteins, leading to a more rapid attainment of the threshold GTP-G-protein level. In the absence of agonist, Al3+ has also been shown to inhibit the ability of receptors to activate Gproteins [13] ; this may be the explanation for the failure of phenylephrine to induce normal free Ca2+ transients in cells pretreated with AP3+ (Fig. 2b) .
Another mechanism for the generation of abnormal free Ca2+ responses is suggested by compelling theoretical evidence predicting the avid binding of A13+ to the vicinal phosphates of Ins(1,4,5)P3 and, presumably, of PtdIns(4,5)P2 [15, 26] . A to release Ca2+ from stores, or an enhanced hydrolysis of Al3+-liganded Ptdlns(4,5)P2 by phosphoinositidase C could all conceivably enhance Ca2`mobilization. The inability of desferrioxamine to reverse the effects of aluminium citrate added in the presence of agonist, even over periods of approx. 30 min (Fig. 3 ) may indicate that Al3+ is binding to intracellular targets with very slow off-rates, the vicinal phosphates of Ins(1,4,5)P3 or Ptdlns(4,5)P2 being prime candidates [15, 26] . However, we do not know how fast desferrioxamine penetrates hepatocytes.
The total Al3+ concentration used in these experiments (5 or 10 /LM) is approx. 10-20-fold higher than normal human plasma levels [27] , although within the range found in the plasma of patients in severe dialysis syndrome (5-8 /LM [28] Fig. 3 . Effects of All' chelation on Ca2" transients Persistent irregular free Ca2" rises are not abolished by superfusion of desferrioxamine, which avidly chelates Al3" (log Kr = 22 [21] ).
Desferrioxamine (500 SM) had no effect on transients induced by phenylephrine (Phe) (results not shown).
common target for Al3+, capable of explaining this element's varied toxicology. 
